Travere Therapeutics Stock Forecast - Double Exponential Smoothing

TVTX Stock  USD 5.80  0.19  3.17%   
The Double Exponential Smoothing forecasted value of Travere Therapeutics on the next trading day is expected to be 5.70 with a mean absolute deviation of  0.26  and the sum of the absolute errors of 15.17. Travere Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Travere Therapeutics stock prices and determine the direction of Travere Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Travere Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Travere Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Travere Therapeutics' systematic risk associated with finding meaningful patterns of Travere Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Travere Therapeutics to cross-verify your projections.
For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.
  
At this time, Travere Therapeutics' Inventory Turnover is fairly stable compared to the past year. Payables Turnover is likely to rise to 1.42 in 2024, whereas Receivables Turnover is likely to drop 6.34 in 2024. . Common Stock Shares Outstanding is likely to drop to about 45.7 M in 2024. Net Loss is likely to rise to about (238.1 M) in 2024.

Open Interest Against 2024-04-19 Travere Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Travere Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Travere Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Travere Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Travere Therapeutics' open interest, investors have to compare it to Travere Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Travere Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Travere. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Travere Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Travere Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Travere Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Travere Therapeutics works best with periods where there are trends or seasonality.

Travere Therapeutics Double Exponential Smoothing Price Forecast For the 20th of April

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Travere Therapeutics on the next trading day is expected to be 5.70 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.10, and the sum of the absolute errors of 15.17.
Please note that although there have been many attempts to predict Travere Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Travere Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Travere Therapeutics Stock Forecast Pattern

Backtest Travere TherapeuticsTravere Therapeutics Price PredictionBuy or Sell Advice 

Travere Therapeutics Forecasted Value

In the context of forecasting Travere Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Travere Therapeutics' downside and upside margins for the forecasting period are 1.85 and 9.54, respectively. We have considered Travere Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
5.80
5.70
Expected Value
9.54
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Travere Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Travere Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0621
MADMean absolute deviation0.257
MAPEMean absolute percentage error0.0324
SAESum of the absolute errors15.1659
When Travere Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Travere Therapeutics trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Travere Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Travere Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Travere Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Travere Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.226.069.90
Details
Intrinsic
Valuation
LowRealHigh
4.438.2712.11
Details
16 Analysts
Consensus
LowTargetHigh
14.7516.2117.99
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Travere Therapeutics. Your research has to be compared to or analyzed against Travere Therapeutics' peers to derive any actionable benefits. When done correctly, Travere Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Travere Therapeutics.

Other Forecasting Options for Travere Therapeutics

For every potential investor in Travere, whether a beginner or expert, Travere Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Travere Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Travere. Basic forecasting techniques help filter out the noise by identifying Travere Therapeutics' price trends.

View Travere Therapeutics Related Equities

 Risk & Return  Correlation

Travere Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Travere Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Travere Therapeutics' current price.

Travere Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Travere Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Travere Therapeutics shares will generate the highest return on investment. By undertsting and applying Travere Therapeutics stock market strength indicators, traders can identify Travere Therapeutics entry and exit signals to maximize returns.

Travere Therapeutics Risk Indicators

The analysis of Travere Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Travere Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting travere stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Travere Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Travere Therapeutics' short interest history, or implied volatility extrapolated from Travere Therapeutics options trading.

Currently Active Assets on Macroaxis

When determining whether Travere Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Travere Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Travere Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Travere Therapeutics Stock:
Check out Historical Fundamental Analysis of Travere Therapeutics to cross-verify your projections.
For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Travere Stock analysis

When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Travere Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Travere Therapeutics. If investors know Travere will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Travere Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.07)
Revenue Per Share
1.956
Quarterly Revenue Growth
0.536
Return On Assets
(0.32)
Return On Equity
(3.09)
The market value of Travere Therapeutics is measured differently than its book value, which is the value of Travere that is recorded on the company's balance sheet. Investors also form their own opinion of Travere Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Travere Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Travere Therapeutics' market value can be influenced by many factors that don't directly affect Travere Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Travere Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Travere Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Travere Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.